- Home
- XPL vs VNRX Comparison
XPL vs VNRX Comparison
Compare XPL & VNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XPL
- VNRX
- Stock Information
- Founded
- XPL 1984
- VNRX N/A
- Country
- XPL United States
- VNRX United States
- Employees
- XPL N/A
- VNRX N/A
- Industry
- XPL Precious Metals
- VNRX Biotechnology: In Vitro & In Vivo Diagnostic Substances
- Sector
- XPL Basic Materials
- VNRX Health Care
- Exchange
- XPL Nasdaq
- VNRX Nasdaq
- Market Cap
- XPL 47.9M
- VNRX 52.4M
- IPO Year
- XPL N/A
- VNRX N/A
- Fundamental
- Price
- XPL $0.67
- VNRX $0.66
- Analyst Decision
- XPL Strong Buy
- VNRX Strong Buy
- Analyst Count
- XPL 1
- VNRX 5
- Target Price
- XPL $1.20
- VNRX $3.88
- AVG Volume (30 Days)
- XPL 115.5K
- VNRX 318.9K
- Earning Date
- XPL 07-29-2025
- VNRX 08-13-2025
- Dividend Yield
- XPL N/A
- VNRX N/A
- EPS Growth
- XPL N/A
- VNRX N/A
- EPS
- XPL N/A
- VNRX N/A
- Revenue
- XPL N/A
- VNRX $1,308,361.00
- Revenue This Year
- XPL N/A
- VNRX $563.72
- Revenue Next Year
- XPL N/A
- VNRX $160.43
- P/E Ratio
- XPL N/A
- VNRX N/A
- Revenue Growth
- XPL N/A
- VNRX 64.16
- 52 Week Low
- XPL $0.54
- VNRX $0.40
- 52 Week High
- XPL $0.98
- VNRX $0.94
- Technical
- Relative Strength Index (RSI)
- XPL 55.55
- VNRX 47.94
- Support Level
- XPL $0.61
- VNRX $0.62
- Resistance Level
- XPL $0.69
- VNRX $0.76
- Average True Range (ATR)
- XPL 0.03
- VNRX 0.08
- MACD
- XPL 0.00
- VNRX -0.02
- Stochastic Oscillator
- XPL 71.12
- VNRX 12.47
About XPL Solitario Resources Corp.
Solitario Resources Corp is exploration company engaging in acquiring, exploring, and developing zinc properties and other precious metals in safe jurisdictions in North and South America. It has joint venture interests in large, high-grade zinc development projects. The Florida Canyon Zinc Project in Peru is a development asset held jointly with Nexa Resources S.A., Golden Crest Project in South Dakota and the Lik Zinc Project represents a large-tonnage, high-grade development project in Alaska in partnership with Teck Resources. In addition, the company has an additional portfolio of exploration properties and royalties in the Americas.
About VNRX VolitionRX Limited
VolitionRX Ltd is a United States-based epigenetics company that applies its Nucleosomics platform through its subsidiaries to develop simple, easy-to-use, cost-effective blood tests to help diagnose and monitor range of life-altering diseases including some cancers and diseases associated with NETosis such as sepsis and COVID-19. The tests are based on the science of Nucleosomics, which is the practice of identifying and measuring nucleosomes in the bloodstream or other bodily fluid - an indication that disease is present. The company is focused on human diagnostics and monitoring but also has a subsidiary focused on animal diagnostics and monitoring.